Vaccines against Genital Herpes: Where Are We? [PDF]
Kim HC, Lee HK.
europepmc +1 more source
[High seroprevalence of syphilis and genital herpes in migrants in transit in Chiapas, MexicoAlta soroprevalência de sífilis e herpes genital em migrantes em trânsito por Chiapas, México]. [PDF]
Sánchez-Alemán MA+6 more
europepmc +1 more source
Local Power: The Role of Tissue-Resident Immunity in Human Genital Herpes Simplex Virus Reactivation. [PDF]
Zhu J, Miner MD.
europepmc +1 more source
Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models. [PDF]
Awasthi S+16 more
europepmc +1 more source
Estimated global and regional economic burden of genital herpes simplex virus infection among 15-49 year-olds in 2016. [PDF]
Chaiyakunapruk N+7 more
europepmc +1 more source
A nonhuman primate model for genital herpes simplex virus 2 infection that results in vaginal vesicular lesions, virus shedding, and seroconversion. [PDF]
Wang K+6 more
europepmc +1 more source
Therapeutic mucosal vaccination of herpes simplex virus type 2 infected guinea pigs with an adenovirus-based vaccine expressing the ribonucleotide reductase 2 and glycoprotein D induces local tissue-resident CD4+ and CD8+ TRM cells associated with protection against recurrent genital herpes. [PDF]
Quadiri A+7 more
europepmc +1 more source
Summary of the Centers for Disease Control and Prevention/National Institute of Allergy and Infectious Diseases Joint Workshop on Genital Herpes: 3-4 November 2022. [PDF]
Connolly KL+7 more
europepmc +1 more source